Skip to main content
. Author manuscript; available in PMC: 2013 Jun 3.
Published in final edited form as: J Immunol. 2010 Mar 5;184(7):3401–3407. doi: 10.4049/jimmunol.0901550

Figure 2.

Figure 2

Effect of multiple injections of CD47 KO splenocytes and co-injection of WT and CD47 KO splenocytes on donor skin allograft survival. (A) Bm1 mice received a single injection of 1×107 WT (sWT-DST) or CD47 KO (sKO-DST) B6 splenocytes at day −7, or 4 daily injections of CD47 KO B6 splenocytes (1×107/injection) from day −7 to day −4 (mKO-DST), followed by skin grafting from B6 donors at day 0. Untreated bm1 mice were used as non-DST controls. (B) Bm1 mice received 1×107 WT or CD47 KO B6 splenocytes, or a mixture (1×107 each) of WT and CD47 KO B6 splenocytes 7 days prior to donor skin grafting (n=6 per group). Data shown are donor skin graft survivals in the indicated groups.